REVB
NASDAQ · Biotechnology
Revelation Biosciences Inc
$1.65
+0.18 (+12.24%)
Open$1.49
Previous Close$1.47
Day High$1.67
Day Low$1.41
52W High$11.30
52W Low$4.89
Volume—
Avg Volume68.9K
Market Cap2.61M
P/E Ratio44.02
EPS$0.21
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+518.8% upside
Current
$1.65
$1.65
Target
$10.21
$10.21
$7.91
$10.21 avg
$15.75
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 725.2K | 710.5K | 685.3K |
| Net Income | -167,658 | -204,058 | -214,742 |
| Profit Margin | -23.1% | -28.7% | -31.3% |
| EBITDA | -214,609 | -243,655 | -229,479 |
| Free Cash Flow | -113,026 | -111,014 | -146,791 |
| Rev Growth | -8.8% | +0.9% | +1.6% |
| Debt/Equity | 0.76 | 0.62 | 0.70 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |